1. LBA54ENTRATA: Randomized, double-blind, phase II study of telaglenastat (tela; CB-839) + everolimus (E) vs placebo (pbo) + E in patients (pts) with advanced/metastatic renal cell carcinoma (mRCC). (1st October 2019) Authors: Motzer, R J; Lee, C-H; Emamekhoo, H; Matrana, M; Percent, I; Hsieh, J J; Hussain, A; Vaishampayan, U N; Graham, R; Liu, S; McCune, S; Shaheen, M; Parmar, H; Shen, Y; Whiting, S H; Tannir, N M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment of prostatic cancer. Issue 6627 (2nd April 1988) Authors: Parmar, H; Phillips, R H; Edwards, L; Partridge, S E; Lightman, S L Journal: BMJ Issue: Volume 296:Issue 6627(1988) Page Start: 1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer. Issue 6631 (30th April 1988) Authors: Parmar, H; Rustin, G; Lightman, S L; Phillips, R H; Hanham, I W; Schally, A V Journal: BMJ Issue: Volume 296:Issue 6631(1988) Page Start: 1229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Medical or surgical orchidectomy. Issue 6787 (25th May 1991) Authors: Parmar, H; Edwards, L E; Phillips, R H; Charlton, C; Lightman, S I Journal: BMJ Issue: Volume 302:Issue 6787(1991) Page Start: 1272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early tumor exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone. Issue 6509 (7th December 1985) Authors: Parmar, H; Phillips, R H; Lightman, S L; Edwards, L Journal: BMJ Issue: Volume 291:Issue 6509(1985) Page Start: 1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗